Estrella Immunopharma, Inc.
ESLA
$0.7936
-$0.0428-5.12%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.82M | -7.31M | -6.09M | -8.36M | -10.10M |
| Total Depreciation and Amortization | -- | -- | -14.50K | -9.00K | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00 | 1.19M | 1.30M | 1.40M | 1.50M |
| Change in Net Operating Assets | -9.19M | -9.95M | -11.01M | -4.70M | 8.09M |
| Cash from Operations | -18.01M | -16.07M | -15.82M | -11.67M | -511.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.07M | 4.96M | 4.82M | 4.69M | -385.30K |
| Cash from Investing | 5.07M | 4.96M | 4.82M | 4.69M | -385.30K |
| Total Debt Issued | 0.00 | 300.00K | 300.00K | 300.00K | 300.00K |
| Total Debt Repaid | -300.00K | -300.00K | -300.00K | -300.00K | -- |
| Issuance of Common Stock | 0.00 | 10.00M | 10.00M | 10.00M | 10.00M |
| Repurchase of Common Stock | -5.58M | -5.43M | -5.16M | -5.07M | -- |
| Issuance of Preferred Stock | 0.00 | 9.02M | 9.02M | 9.02M | 9.02M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.53M | -798.70K | -798.70K | -798.70K | 726.30K |
| Cash from Financing | -7.40M | 12.79M | 13.06M | 13.15M | 20.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.34M | 1.69M | 2.07M | 6.17M | 19.15M |